BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Rethinking Clinical Trials - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Rethinking Clinical Trials
X-ORIGINAL-URL:https://rethinkingclinicaltrials.org
X-WR-CALDESC:Events for Rethinking Clinical Trials
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180509T083000
DTEND;TZID=America/New_York:20180509T170000
DTSTAMP:20260530T183700
CREATED:20180425T192624Z
LAST-MODIFIED:20180503T192838Z
UID:10592-1525854600-1525885200@rethinkingclinicaltrials.org
SUMMARY:Advancing the Science of Patient Input in Medical Product R&D: Towards A Research Agenda
DESCRIPTION:About This Webcast  \nConverting traditionally anecdotal patient input into rigorous\, credible evidence for use by a broad range of stakeholders could better align medical product research and development (R&D) and regulatory decision-making with patient experience of and preferences for disease management and treatment. Accordingly\, many efforts have been launched to advance a science of patient input—the development and use of systematic approaches and tools to collect\, analyze\, and apply patient input to the medical product R&D lifecycle and regulatory decision-making processes. Despite significant progress made in highlighting the value and impact of patient input in medical product R&D\, and momentum towards the development of a science of patient input\, there is a critical need to examine gaps in the knowledge base and other barriers that are hindering the advancement of this field and explore a research agenda for addressing them. \nThe Forum on Drug Discovery\, Development\, and Translation at the National Academies of Sciences\, Engineering\, and Medicine is hosting a one-day workshop to examine gaps in knowledge and other barriers that are hindering the advancement of a science of patient input in medical product R&D\, with consideration of downstream regulatory and post-market decision-making. Subject matter experts representing a range of disciplines will engage in discussions to: \n\nExamine the state of the science of patient input\, including successes and limitations of current efforts.\nExplore gaps in the knowledge base and other barriers that impede progress.\nDiscuss potential components of a research agenda for addressing gaps or barriers to realizing a science of patient input.\n\nThe format of this workshop will be discussion-based and participant-driven\, with a focus on active participation by workshop attendees. Each of the three workshop sessions will feature “lightning round” presentations that will highlight case studies in soliciting and applying patient input throughout medical product R&D\, followed by in-room tabletop exercises and moderated discussion among workshop participants. \nRegister here.
URL:https://rethinkingclinicaltrials.org/event/advancing-the-science-of-patient-input-in-medical-product-rd-towards-a-research-agenda/
END:VEVENT
END:VCALENDAR